GOLD COPD Assessment

Agustí A, Celli BR, Criner GJ, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Introduced the ABE assessment: spirometric grade 1–4 from post-bronchodilator FEV1 % predicted, and groups A/B (few exacerbations, by symptom burden) or E (≥ 2 moderate exacerbations or ≥ 1 leading to hospitalisation).

Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Spirometric grades: GOLD 1 FEV1 ≥ 80% predicted, GOLD 2 50–79%, GOLD 3 30–49%, GOLD 4 < 30%, in a patient with FEV1/FVC < 0.70.